Malignant hypertension laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Malignant hypertension}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Malignant hypertension}} | {{Malignant hypertension}} | ||
{{CMG}} | |||
==Laboratory Findings== | |||
* [[Complete blood count]] | |||
* [[Electrolyte]]s | |||
* [[Coagulation]] profile | |||
* [[Urinalysis]] | |||
* [[Cardiac enzymes]] | |||
* urinary [[catecholamines]] | |||
* [[Thyroid-stimulating hormone]] (TSH) | |||
* 24-hour urine collection for [[vanillylmandelic acid]] (VMA) and catecholamines. | |||
* [[BUN]], [[creatinine]] | |||
Urinalysis may reveal | |||
* [[Proteinuria]] | |||
* Microscopic [[hematuria]] | |||
* RBC or [[hyaline cast]]s. | |||
In patients with [[hyperaldosteronism]] (a secondary cause of hypertension), aldosterone promotes renal potassium wasting, resulting in low serum potassium. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs | [[Category:Needs overview]] | ||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
Latest revision as of 19:51, 22 February 2013
|
Malignant hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Malignant hypertension laboratory findings On the Web |
|
American Roentgen Ray Society Images of Malignant hypertension laboratory findings |
|
Risk calculators and risk factors for Malignant hypertension laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Laboratory Findings
- Coagulation profile
- urinary catecholamines
- 24-hour urine collection for vanillylmandelic acid (VMA) and catecholamines.
- BUN, creatinine
Urinalysis may reveal
- Microscopic hematuria
- RBC or hyaline casts.
In patients with hyperaldosteronism (a secondary cause of hypertension), aldosterone promotes renal potassium wasting, resulting in low serum potassium.